TWI498121B - 含有抗－介白素－４受體（ｉｌ－４ｒ）抗體之安定化配製物 - Google Patents

含有抗－介白素－４受體（ｉｌ－４ｒ）抗體之安定化配製物 Download PDF

Info

Publication number: TWI498121B
Authority: TW; Taiwan
Prior art keywords: antibody; pharmaceutical formulation; liquid pharmaceutical; concentration; polysorbate
Prior art date: 2010-10-06

Application number

TW100135992A

Other languages

English (en)

Chinese (zh)

Other versions

TW201221141A (en

Inventor

Daniel Dix

Xiaolin Tang

Original Assignee

Regeneron Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-10-06

Filing date

2011-10-05

Publication date

2015-09-01

2011-10-05 Application filed by Regeneron Pharma filed Critical Regeneron Pharma

2012-06-01 Publication of TW201221141A publication Critical patent/TW201221141A/zh

2015-09-01 Application granted granted Critical

2015-09-01 Publication of TWI498121B publication Critical patent/TWI498121B/zh

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW100135992A 2010-10-06 2011-10-05 含有抗－介白素－４受體（ｉｌ－４ｒ）抗體之安定化配製物 TWI498121B (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US39028310P	2010-10-06	2010-10-06

Publications (2)

Publication Number	Publication Date
TW201221141A TW201221141A (en)	2012-06-01
TWI498121B true TWI498121B (zh)	2015-09-01

Family

ID=45995014

Family Applications (7)

Application Number	Title	Priority Date	Filing Date
TW100135992A TWI498121B (zh)	2010-10-06	2011-10-05	含有抗－介白素－４受體（ｉｌ－４ｒ）抗體之安定化配製物
TW109131629A TWI782325B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW105134483A TWI679988B (zh)	2010-10-06	2011-10-05	含有抗-介白素-４受體（ｉｌ-４ｒ）抗體之安定化配製物
TW109107375A TWI718890B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW111138434A TWI856388B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW104123984A TWI568445B (zh)	2010-10-06	2011-10-05	含有液態醫藥配製物之預填充針筒
TW108111631A TWI690329B (zh)	2010-10-06	2011-10-05	含有抗-介白素-４受體（ｉｌ-４ｒ）抗體之安定化配製物

Family Applications After (6)

Application Number	Title	Priority Date	Filing Date
TW109131629A TWI782325B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW105134483A TWI679988B (zh)	2010-10-06	2011-10-05	含有抗-介白素-４受體（ｉｌ-４ｒ）抗體之安定化配製物
TW109107375A TWI718890B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW111138434A TWI856388B (zh)	2010-10-06	2011-10-05	含有抗-介白素-4受體(il-4r)抗體之安定化配製物
TW104123984A TWI568445B (zh)	2010-10-06	2011-10-05	含有液態醫藥配製物之預填充針筒
TW108111631A TWI690329B (zh)	2010-10-06	2011-10-05	含有抗-介白素-４受體（ｉｌ-４ｒ）抗體之安定化配製物

Country Status (14)

Country	Link
AR (1)	AR083338A1 (pt)
DK (2)	DK2624865T3 (pt)
ES (2)	ES2820246T3 (pt)
HK (1)	HK1258305A1 (pt)
HR (1)	HRP20181822T1 (pt)
HU (1)	HUE052089T2 (pt)
LT (1)	LT2624865T (pt)
PT (1)	PT3354280T (pt)
RS (1)	RS57850B1 (pt)
SI (1)	SI2624865T1 (pt)
SM (1)	SMT201800488T1 (pt)
TW (7)	TWI498121B (pt)
UA (1)	UA111731C2 (pt)
UY (1)	UY33652A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112015003590A8 (pt)	2012-08-21	2017-10-31	Sanofi Sa	Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
HUE046410T2 (hu) *	2013-06-21	2020-03-30	Sanofi Biotechnology	Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) *	2013-06-21	2019-11-21	Regeneron Pharmaceuticals, Inc.	Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en)	2014-11-14	2016-05-19	Sanofi Biotechnology	Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (pl)	2017-10-30	2024-03-25	Sanofi Biotechnology	Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201029664A (en) *	2008-10-29	2010-08-16	Regeneron Pharma	High affinity human antibodies to human IL-4 receptor
WO2010102241A1 (en) *	2009-03-06	2010-09-10	Genentech, Inc.	Antibody formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2332082B1 (es) *	2008-07-24	2010-10-26	Consejo Superior De Investigaciones Cientificas (Csic) 45%	Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) *	2008-09-10	2016-02-18	니혼 엑스란 고교 (주)	가교 아크릴레이트계 섬유 및 이의 제조방법

2011
- 2011-05-10 UA UAA201305598A patent/UA111731C2/uk unknown
- 2011-10-03 AR ARP110103663 patent/AR083338A1/es not_active Application Discontinuation
- 2011-10-05 TW TW100135992A patent/TWI498121B/zh active
- 2011-10-05 ES ES18161288T patent/ES2820246T3/es active Active
- 2011-10-05 TW TW109131629A patent/TWI782325B/zh active
- 2011-10-05 TW TW105134483A patent/TWI679988B/zh active
- 2011-10-05 TW TW109107375A patent/TWI718890B/zh active
- 2011-10-05 RS RS20181308A patent/RS57850B1/sr unknown
- 2011-10-05 TW TW111138434A patent/TWI856388B/zh active
- 2011-10-05 DK DK11770625.9T patent/DK2624865T3/en active
- 2011-10-05 SM SM20180488T patent/SMT201800488T1/it unknown
- 2011-10-05 TW TW104123984A patent/TWI568445B/zh active
- 2011-10-05 LT LTEP11770625.9T patent/LT2624865T/lt unknown
- 2011-10-05 TW TW108111631A patent/TWI690329B/zh active
- 2011-10-05 HU HUE18161288A patent/HUE052089T2/hu unknown
- 2011-10-05 PT PT181612888T patent/PT3354280T/pt unknown
- 2011-10-05 DK DK18161288.8T patent/DK3354280T3/da active
- 2011-10-05 ES ES11770625.9T patent/ES2687813T3/es active Active
- 2011-10-05 SI SI201131568T patent/SI2624865T1/sl unknown
- 2011-10-06 UY UY33652A patent/UY33652A/es unknown
2018
- 2018-10-31 HR HRP20181822TT patent/HRP20181822T1/hr unknown
2019
- 2019-01-15 HK HK19100671.5A patent/HK1258305A1/zh unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201029664A (en) *	2008-10-29	2010-08-16	Regeneron Pharma	High affinity human antibodies to human IL-4 receptor
WO2010102241A1 (en) *	2009-03-06	2010-09-10	Genentech, Inc.	Antibody formulation

Also Published As

Publication number	Publication date
HK1258305A1 (zh)	2019-11-08
TW201716086A (zh)	2017-05-16
TW202320851A (zh)	2023-06-01
PT3354280T (pt)	2020-09-01
HUE052089T2 (hu)	2021-04-28
DK3354280T3 (da)	2020-09-28
SMT201800488T1 (it)	2018-11-09
TW202026011A (zh)	2020-07-16
TWI690329B (zh)	2020-04-11
TW202102262A (zh)	2021-01-16
UY33652A (es)	2012-04-30
TWI856388B (zh)	2024-09-21
TW201221141A (en)	2012-06-01
RS57850B1 (sr)	2018-12-31
ES2687813T3 (es)	2018-10-29
HRP20181822T1 (hr)	2018-12-28
ES2820246T3 (es)	2021-04-20
TWI718890B (zh)	2021-02-11
TW201542229A (zh)	2015-11-16
TWI782325B (zh)	2022-11-01
SI2624865T1 (sl)	2018-10-30
TWI679988B (zh)	2019-12-21
DK2624865T3 (en)	2018-10-22
TW201924718A (zh)	2019-07-01
AR083338A1 (es)	2013-02-21
LT2624865T (lt)	2018-10-25
UA111731C2 (uk)	2016-06-10
TWI568445B (zh)	2017-02-01

Publication	Publication Date	Title
US11926670B2 (en)	2024-03-12	Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
JP6456470B2 (ja)	2019-01-23	抗ｐｃｓｋ９抗体を含む安定化製剤
TWI498121B (zh)	2015-09-01	含有抗－介白素－４受體（ｉｌ－４ｒ）抗體之安定化配製物
EA042167B1 (ru)	2023-01-20	Стабилизированные композиции, содержащие антитела к рецептору интерлейкина-4 (il-4r)